
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
Edwin M. Posadas, Meghan S. Liel, Virginia Kwitkowski, Lori Minasian, Andrew K. Godwin, Mahrukh M. Hussain, Virginia Espina, Bradford J. Wood, Seth M. Steinberg, Elise C. KohnVolume:
109
Année:
2007
Langue:
english
Pages:
8
DOI:
10.1002/cncr.22545
Fichier:
PDF, 145 KB
english, 2007